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Abstract
Background: Patients suffering from Intermittent Claudication (IC) experience repeated periods
of muscle contraction with low blood flow, throughout the day and this may contribute to the
hypothesised skeletal muscle abnormalities. However, no study has evaluated the consequences of
intermittent contraction with low blood flow on skeletal muscle tissue. Our aim was to generate
this basic physiological data, determining the 'normal' response of healthy skeletal muscle tissue.
We specifically proposed that the metabolic responses to contraction would be modified under
such circumstances, revealing endogenous strategies engaged to protect the muscle adenine
nucleotide pool. Utilizing a canine gracilis model (n = 9), the muscle was stimulated to contract (5
Hz) for three 10 min periods (separated by 10 min rest) under low blood flow conditions (80%
reduced), followed by 1 hr recovery and then a fourth period of 10 min stimulation. Muscle biopsies
were obtained prior to and following the first and fourth contraction periods. Direct arterio-
venous sampling allowed for the calculation of muscle metabolite efflux and oxygen consumption.
Results: During the first period of contraction, [ATP] was reduced by ~30%. During this period
there was also a 10 fold increase in muscle lactate concentration and a substantial increase in
muscle lactate and ammonia efflux. Subsequently, lactate efflux was similar during the first three
periods, while ammonia efflux was reduced by the third period. Following 1 hr recovery, muscle
lactate and phosphocreatine concentrations had returned to resting values, while muscle [ATP]
remained 20% lower. During the fourth contraction period no ammonia efflux or change in muscle
ATP content occured. Despite such contrasting metabolic responses, muscle tension and oxygen
consumption were identical during all contraction periods from 3 to 10 min.
Conclusion: repeated periods of muscle contraction, with low blood flow, results in cessation of
muscle ammonia production which is suggestive of a dramatic reduction in flux through AMP
deaminase.
Background
Intermittent Claudication (IC) is the symptomatic mani-
festation of peripheral vascular disease, suffered by mil-
lions of patients worldwide. IC is thought to occur when
skeletal muscle blood flow fails to increase adequately
during walking [1,2] severely limiting the quality of life of
the patient [3]. The effectiveness of current treatment
strategies for IC is dismal [4-6]. Arguably, this reflects both
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the current inadequacies of available pharmaceutical
medications [4] and the lack of exercise rehabilitation
programs [6]. In order to select potential therapeutic tar-
gets, we must establish a greater understanding of the
physiological responses to repeated periods of skeletal
muscle contraction under low blood flow conditions in
both health and disease. In both preclinical models and in
humans, accelerated muscle fatigue and increased 'anaer-
obic' ATP regeneration is a feature of limb ischemia [7-
11]. This in turn temporally relates to muscle pain and
fatigue experienced by patients [2,12-14]. Evidence for
underlying muscle damage and degeneration in ambula-
tory IC patients has been presented [15,16] but such
observations may reflect co-morbidities and have not
been directly linked to IC symptoms. In the studies by
Holm et al [13] muscle tissue from IC patients demon-
strated an increased mitochondrial enzyme capacity. In
patients with resting ischemia (and loss of mobility) this
increased enzymatic activity was no longer observed [13].
To date Type I muscle fiber content has ranged from 35%
to 70% and markers of mitochondrial capacity have been
elevated, unchanged or reduced; when compared with age
matched controls. Overall, the characteristics of muscle
tissue obtained from the IC patient gives little clue to the
underlying patho-physiology of IC.
When studying muscle metabolism in IC patients, the
impact of repeated period of contraction on muscle
metabolism has never been considered. Furthermore, no
study has examined healthy skeletal muscle during
repeated periods of contraction with low blood flow and
hence the 'normal' physiological responses of healthy
muscle tissue, under such conditions, have not been
defined. Short cycles of complete ischemia are known to
induce a protective response to subsequent prolonged
ischemia (preconditioning) [1,17]. There is little evidence
that ischemia-reperfusion injury contributes to the symp-
toms of IC. It is, however, plausible that the metabolic
response to contraction adapts during periods of intermit-
tent walking and that this alters the metabolism and func-
tion of the muscle. In the present study we characterize for
the first time, the metabolic responses of skeletal muscle,
exposed to repeated periods of contraction with low
blood flow, using the canine gracilis model [18] which
reflects the metabolic responses observed in human skel-
etal muscle under similar circumstances [9]. We were par-
ticularly interested to characterize muscle ATP catabolism
and ammonia production. In humans, a 1 hour recovery
period between two ~3 min maximum knee extension
exercise bouts (with normal blood flow) was sufficient to
attenuate muscle ammonia production [19]. This obser-
vation suggested to us that a 1 hour recovery period may
be sufficient to observe an altered regulation of ATP
homeostasis. Our investigation revealed that skeletal
muscle protects the ATP pool 1 hr following three periods
of 'low flow' contraction and this is associated with a com-
plete lack of ammonia efflux from the muscle tissue.
Results
General model characteristics
Blood flow was fixed at 15.7 ± 0.6 ml min-1 100 g-1 muscle
tissue throughout the study, reflecting a normal resting
value but an 80% reduction in the value observed during
contraction. Resting muscle tension averaged 444 ± 33 g
100 g-1 muscle and was fixed prior to each contraction
period. Resting muscle perfusion pressure ranged from 95
to 111 mmHg (pre-isolation perfusion pressure was ~125
mmHg). During contraction, muscle perfusion pressure
ranged from 55 to 59 mmHg. Arterial hemoglobin con-
centration was 13.8 ± 0.2 g dl and remained stable during
the entire period of study (typically 8–10 hours). Control
of ventilation, using a respiratory pump and room air,
ensured that arterial saturation (SO2 %) was maintained
at ~100%, while arterial PCO2 was stable at 45 ± 1 mmHg
for the duration of the study. Arterial ammonia concentra-
tion varied between 16 and 24 µM and arterial glucose
concentration averaged 6.5 ± 0.1 mM, both remaining sta-
ble throughout the study. Arterial lactate concentration
was 1.2 ± 0.1 mM and was also stable for the duration of
the experiment. Arterial creatine kinase activity (SI unit/L)
varied from 40 ± 5 to 59 ± 19 during the course of the
study with no clear pattern with respect to time. There was
no evidence of any muscle damage at any stage of these
experiments. Additional experiments revealed that during
12 hrs of pump mediated perfusion, peak muscle force
development, checked utilizing a short burst of 5 Hz stim-
ulation, was consistent over time, further demonstrating
the stability of the model (data not shown).
Muscle contractile function and oxygen consumption
During the first period of contraction, peak tension was
3.38 ± 0.2 kg 100 g-1 muscle tissue. During the second and
third periods of contraction, peak tension was reduced to
1.75 ± 0.1 and 1.64 ± 0.1 kg 100 g-1 muscle tissue, respec-
tively. During the fourth period, peak tension recovered to
1.89 ± 0.2 kg 100 g-1 muscle tissue. Time to achieve peak
tension was 27.0 ± 1.1 sec during period 1, 73.9 ± 3.1 sec,
87.0 ± 2.0 sec and 75.1 ± 4.9 sec during each successive
contraction period. Force rapidly declined during the first
minute of contraction during contraction period 1 (1.34 ±
0.08 and 0.84 ± 0.08 kg 100 g-1 muscle tissue at 3 min and
10 min of contraction respectively). During contraction
periods 2, 3 and 4, muscle tension production did not dif-
fer from contraction period 1 at the 3 min time point
(Table 1) or at the end of the 10 min stimulation period
(0.84 ± 0.08, 0.81 ± 0.06 and 0.83 ± 0.07 kg 100 g-1 mus-
cle tissue respectively). The lack of difference in muscle
tension production at 3 min, across stimulation periods,
is consistent with the muscle oxygen consumption dataBMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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from this time point which indicates a similar metabolic
rate (Table 1 and Fig 1).
Intramuscular metabolites
During the first 10 min period of contraction, muscle ATP
concentration fell by ~30% (Table 2). This was accompa-
nied by a 10 fold increase in muscle lactate concentration.
Net PCr degradation was substantial, indicating that the
majority of muscle fibers were actively contracting at the
time of obtaining the 10 min muscle biopsy sample. Fol-
lowing 2 additional periods of muscle contraction, sepa-
rated by 10 min recovery; with 60 min of recovery
following the 3rd period of contraction muscle (See Fig 4),
ATP concentration failed to recover to initial levels (~20%
lower than the initial concentration). However, during the
subsequent contraction period (period 4) ATP levels were
maintained during contraction. Furthermore, the extent
of the decline in PCr concentration was somewhat
reduced (~15%, p = 0.051), while muscle lactate accumu-
lation was ~50% lower than that observed during contrac-
tion period 1 (Table 2).
Muscle ammonia efflux
Ammonia efflux from the contracting muscle was sub-
stantial during contraction periods 1 and 2 (Fig 2) and
somewhat reduced during contraction period 3. The sub-
stantial ammonia efflux during periods 2 and 3 of con-
traction indicates that muscle adenine nucleotide
catabolism continued during both these contraction peri-
ods. It is also interesting to note that muscle ammonia
efflux remained elevated during 6 min following the com-
pletion of the contraction periods. This is consistent with
the idea that temporal efflux reflects ~30% of total ammo-
nia production and therefore there is a delay in the efflux
process. During the 1 hr recovery period ammonia efflux
returned to the baseline value. During the fourth period of
contraction there was a complete lack of ammonia efflux
from the muscle. Despite this, peak tension was the sec-
ond highest out of the 4 periods of stimulation and the
'steady state' tension and oxygen consumption was iden-
tical to the other 3 contraction periods (Table 1). It is
therefore clear that the reduction in ammonia efflux is not
a consequence of lower ATP turnover.
Muscle lactate efflux
During the first period of muscle contraction there was a
10 fold increase in muscle lactate efflux (Fig 3). Muscle
lactate efflux remained elevated during the recovery
period and during contraction periods 2 and 3. This indi-
cates a sustained and relatively high glycolytic flux. Muscle
lactate efflux during period 4 mirrored the reduction in
intramuscular lactate accumulation, being reduced by
~50% (Fig 3). The lactate efflux from the muscle over the
first 60 min of contraction/recovery intervals would
account for ~33% of total muscle glycogen stores (assum-
ing glycogen as the only source of carbohydrate). As rest-
ing canine muscle glycogen concentration is ~250 mmol
kg-1 dry muscle [18], (and ignoring glycogen resynthesis
during the 60 min recovery period) then muscle glycogen
availability would most likely be in excess of 160 mmol
kg-1 dry muscle, prior to contraction period 4 and hence
can not be considered to be depleted. The significant lac-
tate accumulation and efflux during period 4 supports this
interpretation.
Discussion
There is extensive information on the functional and bio-
chemical characteristics of skeletal muscle in response to
a single period of contraction under conditions of low
blood flow [10,20,21]. Responses to intermittent 'cycles'
of skeletal muscle contraction under conditions of low
blood flow have not previously been reported. Our first
Table 1: 
Period 1 Period 2 Period 3 Period 4
VO2 2.3 ± 0.17 2.3 ± 0.16 2.3 ± 0.18 2.4 ± 0.18
Art [O2] 17.9 ± 0.28 17.9 ± 0.3 17.9 ± 0.3 17.6 ± 0.4
Art [CO2] 48.5 ± 0.6 48.5 ± 0.4 48.4 ± 0.5 47.8 ± 0.7
Ven [O2] 3.69 ± 1.02 3.29 ± 0.86 3.19 ± 0.92 2.65 ± 0.73
Ven [CO2] 64.9 ± 1.4 59.0 ± 0.76 58.6 ± 1.16 58.9 ± 1.37
Ven Sat % 18.8 ± 5.3 16.8 ± 4.5 16.3 ± 4.8 14.2 ± 4.1
Tension 1.34 ± 0.08 1.28 ± 0.09 1.20 ± 0.11 1.33 ± 0.12
Ammonia efflux 843 ± 237 1413 ± 217 646 ± 135 -175 ± 76
Lactate efflux 38.9 ± 4.6 46.2 ± 4.9 41.4 ± 4.3 22.0 ± 4.3
Represents metabolic and function data during the 3rd and fourth minute of contraction. Muscle oxygen consumption (VO2) units are ml O2 min-1 
100 g-1 wet tissue and value represents the arterial-venous oxygen content difference multiplied by blood flow. Oxygen (O2) and Carbon dioxide 
(CO2) units are ml/DL where 'art' = arterial and 'Ven' equal venous. Sat = Saturation. Tension produced is kg 100 g-1 wet tissue at 3 min into the 
stimulation protocol. Muscle lactate efflux value represents the venous-arterial [lactate] difference multiplied by blood flow. Venous blood sampling 
was initiated at the 3rd minute and took appropriately 30 sec to obtain.BMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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Skeletal muscle oxygen consumption measured at rest and during the 3rd to fourth minute of contraction (this is when a venous  blood sample was obtained) Figure 1
Skeletal muscle oxygen consumption measured at rest and during the 3rd to fourth minute of contraction (this is when a venous 
blood sample was obtained). Oxygen consumption was calculated from the arterial-venous difference (oxygen content) and 
muscle blood flow. Oxygen consumption during contraction did not differ across the 4 stimulation periods. The black bars at 
the top of the graph represent the period of muscle stimulation.
Table 2: 
Period 1 Period 4
Rest Contraction Rest Contraction
ATP 24.7 ± 1.5 17.4 ± 1.6* 19.7 ± 1.1† 18.7 ± 1.2
PCr 86.1 ± 3.4 13.9 ± 4.0* 95.7 ± 6.0 35.1 ± 7.3*
Cr 55.3 ± 3.4 127.5 ± 3.4* 44.7 ± 4.5 105.3 ± 4.7*
Lactate 9.7 ± 1.6 105.3 ± 9.0* 9.4 ± 2.6 47.9 ± 8.9*†
Intramuscular metabolites prior to and at the end of the first and fourth period of muscle contraction. All metabolites are mmol kg-1 dry muscle. 
*indicates significant change from rest, P < 0.05. †indicates significant difference between period 1 and period 4, P < 0.05. For phosphocreatine, the 
difference between period 1 and period 4 resulted in a p value of 0.051.BMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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new observation is that muscle ATP concentration was
protected during the fourth period of contraction while
the lack of ammonia release indicates that flux through
AMP deaminase was dramatically attenuated. This altered
biochemical response is particularly apparent if periods 2
and 4 are contrasted. In both cases presented contractile
parameters were identical yet ammonia efflux was highest
during the 2nd period and completely attenuated during
the fourth period of contraction.
During intense muscle contraction reamination of IMP to
AMP is thought to be slow [22] and recovery of the ade-
nine nucleotides is thought to be constrained to the post
exercise period. During moderate intensity contraction,
reduced blood flow to the muscle accelerates ATP degra-
dation [18] to levels observed during supra-maximal
exercise [23]. This results in otherwise 'low intensity exer-
cise' having an increased metabolic cost of recovery. The
determinants of recovery following ischemia reflect the
oxidative capacity of the muscle tissue, including oxygen
delivery, but may also include muscle ribose-5-phosphate
availability [24]. In the present study we directly assessed
ATP degradation during the first and fourth periods of
contraction and assessed flux through AMP deaminase
indirectly, during each bout, by measuring ammonia
efflux. Graham et al [25] demonstrated that muscle
ammonia efflux reached a maximum of ~300 µmol per
min during intense one legged cycling, reflecting the net
adenine nucleotide catabolism in the muscle. In the
present study a much higher peak ammonia efflux was
Represents muscle ammonia efflux measured during rest and during the 3rd to fourth minute of contraction (this is when a  venous blood sample was obtained) and during the first 2 minutes of recovery Figure 2
Represents muscle ammonia efflux measured during rest and during the 3rd to fourth minute of contraction (this is when a 
venous blood sample was obtained) and during the first 2 minutes of recovery. Peak ammonia efflux from the muscle occurred 
during the 2nd period of muscle contraction. During the fourth period of contraction there was no measurable release of 
ammonia from the muscle tissue. The black bars at the top of the graph represent the period of muscle stimulation.BMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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observed (1500 µmol min-1 100 g-1 versus 314 µmol per
min per leg) indicating that a relative lack of blood flow
may be a more potent stimulus to adenine nucleotide loss
than the intensity of muscle contraction (absolute ATP
turn-over).
Mechanisms explaining a reduced ammonia production
Given the short recovery period between the first two peri-
ods of contraction, pre-contraction [ATP] is likely to have
been lowered prior to contraction period 2, yet ammonia
efflux was extremely high. This indicates that the 20%
reduction in resting [ATP], prior to the fourth period of
contraction, cannot explain the complete lack of ammo-
nia production. PCr utilization was modestly reduced
during the fourth period of contraction, when compared
with period 1 (p = 0.051). Although not substantial, it is
suggestive of a more rapid increase in ATP derived from
oxidative phosphorylation [8-11,26]. A more rapid
increase in the rate of oxidative ATP regeneration ensures
that ATP homeostasis is better maintained [10]. Given
that there was a 1 hour recovery period, prior to the fourth
period of contraction, our data also provide an indication
that muscle metabolism is altered for a substantially
longer period of time following prior exercise than pres-
ently assumed.
Alterations in substrate utilization can influence muscle
pH during contraction, and hence the activation of AMP
deaminase, See [27]. There was a substantial reduction in
muscle lactate accumulation and a measurable reduction
in muscle lactate efflux. The reduced lactate production
indicates that glycolytic flux was attenuated and hence
Represents muscle lactate efflux measured during rest and during the 3rd to fourth minute of contraction (this is when a venous  blood sample was obtained) and during the first 2 minutes of recovery Figure 3
Represents muscle lactate efflux measured during rest and during the 3rd to fourth minute of contraction (this is when a venous 
blood sample was obtained) and during the first 2 minutes of recovery. Peak lactate efflux muscle was similar during the first 3 
periods of muscle contraction. Following 60 min recovery lactate efflux had returned to baseline. The black bars at the top of 
the graph represent the period of muscle stimulation.BMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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(Table 2 and Fig 3) it is reasonable to suggest that muscle
pH did not decline as much during the fourth period of
contraction when compared with any of the first 3 periods
of contraction. Given that flux through AMP deaminase –
as assessed by muscle ammonia efflux and the change in
muscle [ATP] – was essentially zero during the fourth
period of contraction it is unlikely that the attenuation of
muscle acidosis fully explains the altered regulation of
ATP catabolism but clearly it could have contributed. Less
accumulation of substrate for AMP deaminase or specific
inactivation of AMP deaminase both could explain stabi-
lization of the adenine nucleotide pool and reduced
ammonia production [27].
Although there are no previous studies addressing the
metabolic response of skeletal muscle to repeated contrac-
tions with low blood flow, there are a limited number of
intermittent exercise studies (with high blood flow)
which can be compared with the present data [19,28].
During four bouts of ~3 mins of isotonic contraction with
~3 min of rest between each successive bout, there was a
successive reduction in muscle pH and PCr utilization
[28]. In this case, it is plausible that the reduced PCr utili-
zation reflected a greater resting muscle acetyl group avail-
ability [29]. Graham et al [19,25] provide insight into the
impact of prior exercise on ammonia production. They
demonstrated that a period of exhaustive exercise carried
out 24 hr prior to 3 min intense contraction attenuated
muscle ammonia production by ~50% while the total
work done was similar [19]. This effect was independent
of muscle glycogen status, which remained above 200
mmol kg-1 dry muscle tissue, under all conditions. It is
therefore conceivable that the metabolic response to walk-
ing, in IC patients, could be greatly altered by earlier walk-
ing activity, impacting on the outcome of any clinical
assessment and almost certainly complicating the 'disease'
phenotype when studied in a laboratory setting.
ATP loss can exceed 40% even during a single period of
contraction with low blood flow [20] and thus the cessa-
tion of ammonia efflux during period 4 is highly unlikely
to be a consequence of the 20% lower baseline [ATP].
Under the present experimental conditions amino acid
deamination would represent only a small percentage of
the observed muscle ammonia efflux [30,31]. It could also
be suggested that glutamine synthetase (GS) may have
consumed ammonia, for example, during the fourth
period of contraction. Again, given the rate of ammonia
production observed, we feel that it is highly unlikely that
GS activity is relevant for our observations. Finally,
reduced ammonia production by AMP deaminase may
have also reflected the activation of alternative routes of
AMP metabolism, including 5'nucleotidase. The maximal
capacity of 5'nucleotidase is much lower than AMP
deaminase and since [ATP] did not significantly decline
during the fourth period of contraction we also feel that
this is not a likely explanation for the attenuation of
ammonia production and stabilization of muscle [ATP].
Overview of experimental design Figure 4
Overview of experimental design.BMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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Conclusion
We can hypothesize that following 3 periods of contrac-
tions with low blood flow, adenine nucleotides loss is pre-
vented by an endogenous mechanism, involving
modification of AMP deaminase activity. The present
study also provides support for the idea that flux through
AMP deaminase is not essential for continued muscle
contraction while inhibition of AMP deaminase may rep-
resent a potential strategy for protecting muscle metabo-
lism in peripheral vascular disease patients [32-35].
Methods
Surgical procedures
After an overnight fast, each female dog (Animal Breeding
Unit, PGRD UK, n = 9) was anaesthetized with sodium
pentobarbitone (45 ± 1 mg/kg body mass (bm) followed
by continuous infusion at 0.10 ± 0.01 mg/kg/min i.v.
(Sagatal, Rhône Merieux, Harlow, UK). The trachea was
intubated and the dogs were artificially ventilated (24
cycles/min, tidal volume = 13 – 15 ml/kg). The right bra-
chial artery was cannulated and systemic blood pressure
was recorded using a pressure transducer and chart
recorder. The left brachial artery and vein were cannulated
for collection of arterial blood samples for monitoring of
blood parameters (e.g. pH, hemoglobin (Hb), PCO2 and
PO2) using the Radiometer ABL 625GL (Copenhagen)
and venous infusion of heparin, bicarbonate or saline. A
gracilis muscle was vascularly isolated, leaving only the
main arterial and venous blood flows intact. The distal
tendon of the muscle was attached to an isometric force
transducer (Grass FTC 10, Quincy, Medfield, MA, USA).
The popliteal artery was catheterized for recording gracilis
muscle perfusion pressure. Heparin was infused following
surgery, (Multiparin, 1 U/kg/bm/min) for the duration of
the experiment. The femoral artery supplying each gracilis
muscle was cannulated proximally and distally and
attached sequentially to a perfusion pump (Minipuls 3,
Gilson, Villiers le bel, France). The muscle blood flow was
fixed by setting the perfusion pump at 6.1 ± 0.1 ml/min.
We have previously established this as being similar to the
resting flow rate in the gracilis muscle [18]. This flow rate
was maintained for the duration of the experiment and
equates to ~20% of the normal flow observed when this
muscle was stimulated to contract with the blood supply
intact at 3 Hz twitch. All experiments were carried out in
full accordance with the United Kingdom Home Office
Animals (Scientific Procedures) Act of 1986, and
approved by the local ethics committee.
Muscle stimulation parameters and blood sampling
The resting length of the muscle was altered to obtain a
standard tension of ~400 g/100 g muscle. After a 20 min
equilibrium period, baseline values were collected (blood
samples and muscle biopsies) and then muscle contrac-
tion was induced via electrical stimulation of the obtura-
tor nerve (Grass S88 stimulator, Quincy, Medfield, MA,
USA). Square-wave impulses of 0.1 msec duration, 5 Hz
frequency and a supramaximal voltage (10 V), resulting in
complete muscle fiber recruitment and peak twitch ten-
sion, were applied for 3 periods of 10 min (with 10 min
recovery) followed by 1 hour recovery and then a fourth
10 min period of contraction (as shown in Figure 4). Arte-
rial blood samples were taken throughout the experimen-
tal period (for monitoring the stability of the animal) and
did not demonstrate any significant variation over time.
Venous blood samples were obtained to calculate oxygen
uptake and ammonia and lactate efflux. The difference
between arterial concentration and venous concentration
was used, along with the blood flow parameter, to make
such calculations. Venous samples were obtained at rest,
just prior to the onset of contraction, and at 3 min after
the onset of contraction and 6 min after the cessation of
contraction. In each case venous sampling took appropri-
ately 30 sec.
Metabolite analysis
Blood gases, whole blood lactate and glucose were meas-
ured using the Radiometer ABL 625GL (Copenhagen).
The analyzer was calibrated on a daily basis according to
the manufactures instructions. Plasma ammonia was
determined in 1-ml blood samples treated according to
the standard instructions (Ammonia-Test Wako, Wako
Chemicals, Osaka, Japan), and indophenol was measured
using a spectrophotometer at a wavelength of 630 nm
(UV-2400PC, Shimadzu, Tokyo, Japan). All biopsy sam-
ples were stored in liquid nitrogen. Subsequently, a por-
tion was freeze dried, dissected free from visible
connective tissue and blood, powdered and extracted in
0.5 M perchloric acid containing 1 mM EDTA. Following
centrifugation, the supernatant was neutralized with 2.2
M KHCO3 and used for determination of ATP, phospho-
creatine (PCr), creatine and lactate as previously described
[18] with the exception that a 96-well plate format was
utilized using a Spectromax Plus (Molecular Devices). All
data are reported as mean ± SE. Analysis of variance was
utilized to determine significant changes with respect to
time, followed by post-hoc significance testing. A paired t-
test was used to compare the intramuscular metabolic dif-
ferences. Significance was accepted at the 5% level.
Abbreviations
ATP adenosine triphosphate
AMP adenosine monophosphate
IMP inosine monophosphate
PCr phosphocreatine
IC Intermittent ClaudicationBMC Physiology 2005, 5:11 http://www.biomedcentral.com/1472-6793/5/11
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GS glutamine synthetase
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